Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.930
+0.010 (0.52%)
At close: Jan 31, 2025, 4:00 PM
1.902
-0.028 (-1.45%)
After-hours: Jan 31, 2025, 6:59 PM EST
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $311.81 million as of January 31, 2025. Its market cap has decreased by -85.60% in one year.
Market Cap
311.81M
Enterprise Value
-26.75M
1-Year Change
-85.60%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $311.81M, a decrease of -87.93%. That is a compound annual growth rate of -78.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 311.81M | -81.79% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.32B |
| UnitedHealth Group | 499.25B |
| Novo Nordisk | 375.61B |
| Johnson & Johnson | 366.32B |
| AbbVie | 324.98B |
| Merck & Co. | 249.98B |
| Thermo Fisher Scientific | 228.64B |
| Abbott Laboratories | 221.89B |